Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011

International Journal of Food Microbiology

Volumn 196, Issue , 2015, Pages 84-93

  Mangen, Marie Josée J ^a   Bouwknegt, Martijn ^b   Friesema, Ingrid H M ^b   Haagsma, Juanita A ^b   Kortbeek, Laetitia M ^b   Tariq, Luqman ^b   Wilson, Margaret ^c   van Pelt, Wilfrid ^b   Havelaar, Arie H ^b,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Risk Sciences International ^*  (Canada)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Attribution; Costs; DALY; Direct healthcare costs; Foodborne pathogens; Indirect non healthcare costs

Indexed keywords

ARTICLE; BACILLUS CEREUS; BEEF; CAMPYLOBACTER; CLOSTRIDIUM PERFRINGENS; COST OF ILLNESS; CRYPTOSPORIDIUM; FATALITY; FOOD ORGANISM; FOODBORNE PATHOGEN; GIARDIA; HEALTH CARE COST; HEPATITIS A VIRUS; HEPATITIS E VIRUS; HUMAN; INCIDENCE; LAMB; LISTERIA MONOCYTOGENES; LISTERIOSIS; NOROVIRUS; PORK; POULTRY; ROTAVIRUS; SALMONELLA; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; TOXOPLASMA GONDII; ANIMAL; CALICIVIRIDAE INFECTIONS; ECONOMICS; FOOD CONTROL; MEAT; MICROBIOLOGY; NETHERLANDS; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ANIMALIA; CAMPYLOBACTER; CLOSTRIDIUM PERFRINGENS; NOROVIRUS; ROTAVIRUS; STAPHYLOCOCCUS AUREUS; TOXOPLASMA GONDII;

ANIMALS; CALICIVIRIDAE INFECTIONS; COST OF ILLNESS; FOOD MICROBIOLOGY; HEALTH CARE COSTS; HUMANS; INCIDENCE; LISTERIOSIS; MEAT; NETHERLANDS; NOROVIRUS;

EID: 84919430395     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2014.11.022     Document Type: Article

References (39)

1. Belli P., Anderson J.R., Barnum H.N., Dixon J.A., Tan J.-P. Economic Analysis of Investment Operations - Analytical Tools and Practical Applications 2001, World Bank, Washington D.C.
2. Borgen K., Herremans T., Duizer E., Vennema H., Rutjes S., Bosman A., de Roda Husman A.M., Koopmans M. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect. Dis. 2008, 8:61. 10.1186/1471-2334-8-61.
3. Bouwknegt M., Friesema I.H.M., Van Pelt W., Havelaar A.H. Disease burden of food-related pathogens in the Netherlands, 2011. RIVM Letter Report 330331006/2013 2013, National Institute for Public Health and the Environment, Bilthoven, (Available online: http://www.rivm.nl/dsresource?objectid=rivmp:209533&type=org&disposition=inline&ns_nc=1).
4. Bouwknegt M., van Pelt W., Kubbinga M.E., Weda M, Havelaar A.H. Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use. Eurosurveillance 2014, 19(32). pii=20873.
5. De Wit M.A.S., Koopmans M.P.G., Kortbeek L.M., Van Leeuwen N.J., Vinje J., Van Duynhoven Y.T.H.P. Etiology of gastroenteritis in sentinel general practices in the Netherlands. Clin. Infect. Dis. 2001, 33:280-288. 10.1086/321875.
6. De Wit M.A.S., Koopmans M.P.G., Kortbeek L.M., Wannet W.J.B., Vinje J., van Leusden F., Bartelds A.I.M., van Duynhoven Y.T.H.P. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am. J. Epidemiol. 2001, 154:666-674. 10.1093/aje/154.7.666.
7. Friesema I.H.M., de Jager C.M., van der Zwaluw W.K., Notermans D.W., van Heerwaarden C.A.M., Heuvelink A.E., van der Ende A., Spanjaard L., van Pelt W. Intensive surveillance van Listeria monocytogenes in Nederland, 2009. Infectieziekten Bull. 2011, 22(2):67-71. (In Dutch).
8. Friesema I.H.M., de Boer R.F., Duizer E., Kortbeek L.M., Notermans D.W., Smeulders A., Bogerman J., Pronk M.J.H., Uil J.J., Brinkman K., Koopmans M.P.G., Kooistra-Smid A.M.D., van Duynhoven Y.T.H.P. Aetiology of acute gastroenteritis in adults requiring hospitalization in the Netherlands. Epidemiol. Infect. 2012, 140(10):1780-1786. on behalf of the GEops Working Group. 10.1017/S0950268811002652.
9. Friesema I.H.M., de Boer R.F., Duizer E., Kortbeek L.M., Notermans D.W., Norbruis O.F., Bezemer D.D.L., van Heerbeek H., van Andel R.N.J., van Enk J.G., Fraaij P.L.A., Koopmans M.P.G., Kooistra-Smid A.M.D., van Duynhoven Y.T.H.P. Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(4):405-415. 10.1007/s10096-011-1320-0.
10. Friesema I.H.M., Lugnér A.K., Van Duynhoven Y.T.H.P. Costs of gastroenteritis in the Netherlands, with special attention for severe cases. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(8):1895-1900. on behalf of the GEops Working Group. 10.1007/s10096-011-1518-1.
11. Goettsch W.G., van den Boom G., Breekveld-Postma N.S., Smout A.J.P.M., Herings R.M.C. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study. Pharmacoepidemiol. Drug Saf. 2004, 13(11):803-810. 10.1002/pds.997.
12. Gold M.R., Stevenson D., Fryback D.G. HALYs and QALYs and DALYs, oh my: similarities and differences in summary measures of population health. Annu. Rev. Public Health 2002, 23:115-134. 10.1146/annurev.publhealth.23.100901.140513.
13. Haagsma J.A., van der Zanden B.P., Tariq L., Van Pelt W., Van Duynhoven Y.T.H.P., Havelaar A.H. Disease burden and costs of selected foodborne pathogens in the Netherlands, 2006. RIVM Rapport 330331001/2009 2009, National Institute for Public Health and the Environment, Bilthoven, (Available online: http://www.rivm.nl/bibliotheek/rapporten/330331001.pdf).
14. Haagsma J.A., Siersema P.D., de Wit N.J., Havelaar A.H. Disease burden of post-infectious irritable bowel syndrome in the Netherlands. Epidemiol. Infect. 2010, 138(11):1650-1656. 10.1017/S0950268810000531.
15. Hakkaart-van Roijen L., Tan S.S., Bouwmans C.A.M. Handleiding voor kostenonderzoek - Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg 2010, College voor zorgverzekeringen, Diemen.
16. Havelaar A.H., De Wit M.A.S., van Koningsveld R., van Kempen E. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol. Infect. 2000, 125(3):505-522.
17. Havelaar A.H., van Duynhoven Y.T.H.P., Nauta M.J., Bouwknegt M., Heuvelink A.E., de Wit G.A., Nieuwenhuizen M.G.M., van de Kar N.C.A.J. Disease burden in the Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiol. Infect. 2004, 132(3):467-484. 10.1017/S0950268804001979.
18. Havelaar A.H., Kemmeren J.M., Kortbeek L.M. Disease burden of congenital toxoplasmosis. Clin. Infect. Dis. 2007, 44(11):1467-1474. 10.1086/517511.
19. Havelaar A.H., Galindo A.V., Kurowicka D., Cooke R.M. Attribution of foodborne pathogens using structured expert elicitation. Foodborne Pathog. Dis. 2008, 5(5):649-659. 10.1089/fpd.2008.0115.
20. Havelaar A.H., Haagsma J.A., Mangen M.J.J., Kemmeren J.M., Verhoef L.P.B., Vijgen S.M.C., Wilson M., Friesema I.H.M., Kortbeek L.M., van Duynhoven Y.T.H.P., van Pelt W. Disease burden of foodborne pathogens in the Netherlands, 2009. Int. J. Food Microbiol. 2012, 156(3):231-238. 10.1016/j.ijfoodmicro.2012.03.029.
21. Hoffmann S., Batz M.B., Morris J.G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J. Food Prot. 2012, 75(7):1292-1302. 10.4315/0362-028X.JFP-11-417.
22. Kemmeren J.M., Mangen M.-J.J., Van Duynhoven Y.T.H.P., Havelaar A.H. Priority setting of foodborne pathogens: disease burden and costs of selected enteric pathogens. RIVM Rapport 330080001/2006 2006, National Institute of Public Health and Environment, Bilthoven, (Available online: http://www.rivm.nl/bibliotheek/rapporten/330080001.pdf).
23. Kortbeek L.M., Hofhuis A., Nijhuis C.D.M., Havelaar A.H. Congenital toxoplasmosis and DALYs in the Netherlands. Mem. Inst. Oswaldo Cruz 2009, 104(2):370-373.
24. Lake R.J., Cressey P.J., Campbell D.M., Oakley E. Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Anal. 2010, 30(5):743-752. 10.1111/j.1539-6924.2009.01269.x.
25. Le Pen C., Ruszniewski P., Gaudin A.-F., Amouretti M., Bommelaer G., Frexinos J., Poynard T., Maurel F., Priol G., Bertin C. The burden cost of French patients suffering from irritable bowel syndrome. Scand. J. Gastroenterol. 2004, 39(4):336-343.
26. Mangen M.-J.J., Havelaar A.H., Bernsen R.A.J.A.M., Van Koningsveld R., de Wit G.A. The costs of human Campylobacter infections and sequelae in the Netherlands: a DALY and cost-of-illness approach. Acta Agric. Scand. Sect. C Econ. 2005, 2(1):35-51. 10.1080/16507540510033451.
27. Mangen M.-J.J., Plass D., Havelaar A.H., Gibbons C., Cassini A., Mühlberger N., van Lier A., Haagsma J.A., Brooke R.J., Lai T., de Waure C., Kramarz P., Kretzschmar M.E.E., on behalf of the BCoDE consortium The pathogen- and incidence-based DALY approach: an appropriate methodology for estimating the burden of infectious diseases. PLoS One 2013, 8(11):e79740. 10.1371/journal.pone.0079740.
28. Muller-Lissner S.A., Pirk O. Irritable bowel syndrome in Germany. A cost of illness study. Eur. J. Gastroenterol. Hepatol. 2002, 14(12):1325-1329.
29. NHG Multidisciplinaire richtlijn Diagnostiek en behandeling van het prikkelbaredarmsyndroom 2011, Nederlands Huisartsen Genootschap, Utrecht, (Available online: http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/Multidisciplinaire-Richtlijnen.htm).
30. Ruzante J.M., Davidson V.J., Caswell J., Fazil A., Cranfield J.A.L., Henson S.J., Anders S.M., Schmidt C., Farber J.M. A multifactorial risk priorization framework for foodborne pathogens. Risk Anal. 2010, 30(5):724-742. 10.1111/j.1539-6924.2009.01278.x.
31. Ruzante J.M., Majowicz S.E., Fazil A., Davidson V.J. Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001-2004. Epidemiol. Infect. 2011, 139(6):937-945. 10.1017/S0950268810001883.
32. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.-A., Roy S.L., Jones J.L., Griffin P.M. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 2011, 17(1):7-15. 10.3201/eid1701.P11101.
33. Shin H., Lee S., Kim J.-S., Kim J., Han K.-H. Socioeconomic costs of foodborne disease using the cost-of-illness model: applying the QALY method. J. Prev. Med. Public Health 2010, 43(4):352-361. 10.3961/jpmph.2010.43.4.352.
34. Slobbe L.C.J., Smit J.M., Groen J., Poos M.J.J.C., Kommer G.J. Kosten van ziekten in Nederland 2007 - Trends in de Nederlandse zorguitgaven 1999-2010. RIVM Rapport 270751023/2011 2011, National Institute of Public Health and the Environment, Bilthoven, (Available at: http://www.rivm.nl/bibliotheek/rapporten/270751023.pdf).
35. Tam C.C., O'Brien S.J., Tompkins D.S., Bolton F.J., Berry L., Dodds J., Choudhury D., Halstead F., Iturriza-Gómara M., Mather K., Rait G., Ridge A., Rodrigues L.C., Wain J., Wood B. Gray JJ; IID2 Study Executive Committee. Clin Infect Dis 2012 May, 54(9):1275-1286.
36. Tariq L., Haagsma J., Havelaar A. Cost of illness and disease burden in the Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. J. Food Prot. 2011, 74(4):545-552. 10.4315/0362-028X.JFP-10-252.
37. Van de Laar M.J.W., Wijgergangs L.M., Rijlaarsda J., de Wit A. Vaccineren tegen hepatitis A: een verkenning van kosten. Infectieziekten Bull. 2000, 11:262-266.
38. Van der Valk M.E., Mangen M.-J.J., Leenders M., Dijkstra G., Van Bodegraven A.A., Fidder H.H., De Jong D.J., Pierik M., van der Woude C.J., Romberg-Camps M.J.L., Clemens C.H.M., Jansen J.M., Mahmmod N., van de Meeberg P.C., van der Meulen-de Jong A.E., Ponsioen C.Y., Bolwerk C.J.M., Vermeijden J.R., Siersema P.D., van Oijen M.G.H., Oldenburg B. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy - results from the COIN study. Gut 2014, 63(1):72-79. on behalf of the Coin Study Group and the Dutch Initiative on Crohn and Colitis. 10.1136/gutjnl-2012-303376.
39. Vijgen S.M.C., Mangen M.J.J., Kortbeek L.M., Van Duynhoven Y.T.H.P., Havelaar A.H. Disease burden and related costs of cryptosporidiosis and giardiasis in the Netherlands. RIVM Report 330081001/2007 2007, National Institute of Public Health and Environment, Bilthoven.